Skip to main content

Hate Driving Your Cat to the Vet? FDA Just Approved a Drug for That

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 21, 2023.

By Ernie Mundell HealthDay Reporter

TUESDAY, Nov. 21, 2023 -- If you belong to one of the 46 million American households with a cat, you already know how stressful a trip to the vet can be for your feline -- and you.

Rescue might be on the way: The U.S. Food and Drug Administration on Friday approved a new medicine to help calm cat anxiety.

The pill is called Bonqat, and it's designed "for the alleviation of acute anxiety and fear associated with transportation and veterinary visits in cats," the FDA said in a news release announcing the approval.

"The drug is administered orally approximately 1.5 hours before the start of the transportation or veterinary visit and can be given on two consecutive days," the agency added.

Bonqat contains pregabalin, a drug that calms overactive nerves. Bonqat is the first FDA-approved drug to contain pregabalin.

According to information from the VCA Animal Hospitals, some cats can develop severe anxiety and motion sickness being transported to the vet's office (or anywhere). Symptoms can range from lots of meowing, lip smacking and drooling, to stress-induced motion sickness that can trigger urination and defecation in anxious cats.

Medications given before a vet trip might help.

The FDA approval of Bonqat was based on real-world trials conducted by the drug's Finnish maker, Orion Corp. People whose cats had a history of fear and anxiety during veterinary visits were asked to bring their felines to a vet for a physical exam.

In one of the trips, Bonqat was given to the cat prior to the visit.

"A little over half of cats given Bonqat had a good to excellent response during both transportation and the veterinary visit compared to about one-third of cats given placebo," the FDA said. "In addition, 83 of 108 (77%) cats given Bonqat showed improvement in levels of fear and anxiety over the course of the two physical examinations, compared to 46 of 101 (46%) cats given placebo."

Some temporary side effects from the drug -- mild sedation, lethargy and balance issues -- were noted.

Because Bonqat has the potential to be diverted for misuse by people it is being approved as a prescription-only drug, the FDA said.

Pet owners should also take care handling the drug, "including avoiding contact with a person’s skin, eyes, and other mucus membranes," the agency said.

Sources

  • U.S. Food and Drug Administration, statement, Nov. 17, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

Read this next

How Handing a Child a Screen During a Tantrum Could Backfire Long-Term

TUESDAY, July 2, 2024 -- When your preschooler pitches a fit, handing them a smartphone or tablet is probably the fastest -- and the worst -- way to stop it, a new study...

Americans' Interest in Microdosing Psychedelics Is Growing

MONDAY, July 1, 2024 -- A study based on online Google searches suggests surging U.S. interest in microdosing psychedelics, such as psilocybin, as rules around the use of such...

Not 'Out of Your League': Folks Tend to Marry People as Attractive as They Are

MONDAY, July 1, 2024 -- People largely date and marry people in their own “league,” as far as beauty is concerned, a new review finds. Men and women are fairly...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.